150 related articles for article (PubMed ID: 32509767)
1. Practice Patterns for the Treatment of Uveal Melanoma with Iodine-125 Plaque Brachytherapy: Ocular Oncology Study Consortium Report 5.
Binder C; Mruthyunjaya P; Schefler AC; Seider MI; Crilly R; Hung A; Meltsner S; Mowery Y; Kirsch DG; Teh BS; Jennelle RLS; Studenski MT; Liu W; Lee C; Hayman JA; Kastner B; Hadsell M; Skalet AH
Ocul Oncol Pathol; 2020 May; 6(3):210-218. PubMed ID: 32509767
[TBL] [Abstract][Full Text] [Related]
2. Dosimetry of (125)I and (103)Pd COMS eye plaques for intraocular tumors: report of Task Group 129 by the AAPM and ABS.
Chiu-Tsao ST; Astrahan MA; Finger PT; Followill DS; Meigooni AS; Melhus CS; Mourtada F; Napolitano ME; Nath R; Rivard MJ; Rogers DW; Thomson RM
Med Phys; 2012 Oct; 39(10):6161-84. PubMed ID: 23039655
[TBL] [Abstract][Full Text] [Related]
3. Dosimetric comparison of circular Eye Physics and Collaborative Ocular Melanoma Study plaques to treat uveal melanoma.
Dean MK; Studenski MT; Paez-Escamilla MA; Walter SD; Kwon D; Markoe AM; Harbour JW; Samuels SE
Brachytherapy; 2019; 18(3):404-410. PubMed ID: 30797699
[TBL] [Abstract][Full Text] [Related]
4. EyeDose: An open-source tool for using published Monte Carlo results to estimate the radiation dose delivered to the tumor and critical ocular structures for
Deufel CL; McCauley Cutsinger S; Corbin KS; Dalvin LA; Petersen IA
Brachytherapy; 2021; 20(1):189-199. PubMed ID: 33187821
[TBL] [Abstract][Full Text] [Related]
5. Effect of radiation dose on ocular complications after iodine brachytherapy for large uveal melanoma: empirical data and simulation of collimating plaques.
Puusaari I; Heikkonen J; Kivelä T
Invest Ophthalmol Vis Sci; 2004 Oct; 45(10):3425-34. PubMed ID: 15452045
[TBL] [Abstract][Full Text] [Related]
6. MRI-based treatment planning and dose delivery verification for intraocular melanoma brachytherapy.
Zoberi JE; Garcia-Ramirez J; Hedrick S; Rodriguez V; Bertelsman CG; Mackey S; Hu Y; Gach HM; Rao PK; Grigsby PW
Brachytherapy; 2018; 17(1):31-39. PubMed ID: 28818442
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of medium choroidal melanomas treated with ruthenium brachytherapy guided by three-dimensional pretreatment modeling.
Browne AW; Dandapani SV; Jennelle R; Stevanovic M; Lee TC; Murphree AL; Kampp TD; Astrahan MA; Kim JW; Berry JL
Brachytherapy; 2015; 14(5):718-25. PubMed ID: 26073224
[TBL] [Abstract][Full Text] [Related]
8. Prescribing to tumor apex in episcleral plaque iodine-125 brachytherapy for medium-sized choroidal melanoma: A single-institutional retrospective review.
Vonk DT; Kim Y; Javid C; Gordon JD; Stea B
Brachytherapy; 2015; 14(5):726-33. PubMed ID: 26051804
[TBL] [Abstract][Full Text] [Related]
9. The American Brachytherapy Society consensus guidelines for plaque brachytherapy of uveal melanoma and retinoblastoma.
;
Brachytherapy; 2014; 13(1):1-14. PubMed ID: 24373763
[TBL] [Abstract][Full Text] [Related]
10. Dose Distributions and Treatment Margins in Ocular Brachytherapy with 106Ru Eye Plaques.
Stöckel E; Eichmann M; Flühs D; Sommer H; Biewald E; Bornfeld N; Spaan B; Sauerwein W
Ocul Oncol Pathol; 2018 Sep; 4(2):122-128. PubMed ID: 30320093
[TBL] [Abstract][Full Text] [Related]
11. Palladium 103 plaque radiotherapy for uveal melanoma. Clinical experience.
Finger PT; Buffa A; Mishra S; Berson A; Bosworth JL; Vikram B
Ophthalmology; 1994 Feb; 101(2):256-63. PubMed ID: 8115147
[TBL] [Abstract][Full Text] [Related]
12. Personalized treatment planning in eye brachytherapy for ocular melanoma: Dosimetric analysis on ophthalmic structure at risk.
Itta F; Liuzzi R; Farella A; Porri G; Pacelli R; Conson M; Oliviero C; Buonanno F; Breve MA; Cennamo G; Clemente S; Cella L
Phys Med; 2020 Aug; 76():285-293. PubMed ID: 32738776
[TBL] [Abstract][Full Text] [Related]
13. Early outcomes of uveal melanoma treated with intraoperative ultrasound guided brachytherapy using custom built plaques.
Tann AW; Teh BS; Scarboro SB; Lewis GD; Bretana ME; Croft PC; Raizen Y; Butler EB; Kim RS; Chevez-Barrios P; Schefler AC
Pract Radiat Oncol; 2017; 7(4):e275-e282. PubMed ID: 28377140
[TBL] [Abstract][Full Text] [Related]
14. Long-term visual acuity outcomes in patients with uveal melanoma treated with 125I episcleral OSU-Nag plaque brachytherapy.
Wisely CE; Hadziahmetovic M; Reem RE; Hade EM; Nag S; Davidorf FH; Martin D; Cebulla CM
Brachytherapy; 2016; 15(1):12-22. PubMed ID: 26525215
[TBL] [Abstract][Full Text] [Related]
15. Experimental validation of a new COMS-like 24 mm eye plaque for the treatment of large ocular melanoma tumors.
McCauley Cutsinger S; Forsman R; Corner S; Deufel CL
Brachytherapy; 2019; 18(6):890-897. PubMed ID: 31444131
[TBL] [Abstract][Full Text] [Related]
16. A practical approach to estimating optic disc dose and macula dose without treatment planning in ocular brachytherapy using
Lee YC; Lin SC; Kim Y
Radiat Oncol; 2018 Nov; 13(1):221. PubMed ID: 30424782
[TBL] [Abstract][Full Text] [Related]
17. Delivered dose uncertainty analysis at the tumor apex for ocular brachytherapy.
Morrison H; Menon G; Larocque MP; Jans HS; Weis E; Sloboda RS
Med Phys; 2016 Aug; 43(8):4891. PubMed ID: 27487906
[TBL] [Abstract][Full Text] [Related]
18. (106)Ru plaque brachytherapy for uveal melanoma: factors associated with local tumor recurrence.
Barker CA; Francis JH; Cohen GN; Marr BP; Wolden SL; McCormick B; Abramson DH
Brachytherapy; 2014; 13(6):584-90. PubMed ID: 24880583
[TBL] [Abstract][Full Text] [Related]
19. The impact of prescription depth, dose rate, plaque size, and source loading on the central axis using 103Pd, 125I, and 131Cs.
Rivard MJ; Melhus CS; Sioshansi S; Morr J
Brachytherapy; 2008; 7(4):327-35. PubMed ID: 18782684
[TBL] [Abstract][Full Text] [Related]
20. GEC-ESTRO survey of
De Brabandere M; Placidi E; Siebert FA; Carlsson Tedgren Å; Slocker Escarpa A; Tagliaferri L; Andrássy M; Schulz C; Fog LS
Radiother Oncol; 2024 Apr; 193():110114. PubMed ID: 38309583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
